Episode 242
In this solo episode of The Energy Code, Mike dives into two cutting-edge studies that expand the already impressive profile of Urolithin A, the postbiotic powerhouse derived from pomegranate. The first paper explores how Urolithin A promotes peripheral nerve regeneration via TFEB-mediated mitophagy and suppression of the NLRP3 inflammasome, while the second study—a randomized, placebo-controlled trial in humans—uncovers Urolithin A’s ability to rejuvenate the immune system by increasing naive CD8+ T cells, boosting fatty acid oxidation, and reprogramming immune gene expression.
Key topics include:
The dual role of Urolithin A in nerve repair: clearing damaged mitochondria & suppressing inflammation
Why mitophagy is a linchpin in mitochondrial health, longevity, and disease prevention
How TFEB acts as a master switch for cellular detox and mitochondrial renewal
New clinical data showing Urolithin A’s impact on immune cell function and inflammatory aging
Why mitochondrial-targeted compounds (Urolithin A, methylene blue, PQQ, etc.) are foundational to healthspan
Plus, Mike teases the release of two new BioBlue formulations — BioBlue Lite and BioBlue Leuco Lite — featuring a simplified formula of just deuterium-depleted water and pharmaceutical-grade methylene blue or leucomethylene blue.
🔗 Listen now to get a front-row seat to the future of mitochondrial medicine and discover why Urolithin A may be one of the most versatile compounds in the longevity space.
Key Quotes from Dr. Mike “Urolithin A isn’t just for energy. It’s a bioenergetic modulator that may influence neuroregeneration, immune aging, and so much more.” “Mitophagy is one of the most underrated physiological processes in the longevity space. Without it, you’re just accumulating dysfunctional mitochondria—and that’s a recipe for decline.”
Published on 11 hours ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate